2. Gene
  3. Cga - glycoprotein hormones, alpha polypeptide Gene

Cga - glycoprotein hormones, alpha polypeptide Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

同用名: Gpa1

基因 ID: 116700 | 基因类型: protein coding

关于 Cga

功能概要

Predicted to enable follicle-stimulating hormone activity. Predicted to be involved in several processes, including positive regulation of steroid biosynthetic process; regulation of signaling receptor activity; and thyroid hormone generation. Predicted to act upstream of or within several processes, including gonadotropin secretion; negative regulation of organ growth; and thyroid gland development. Predicted to be part of follicle-stimulating hormone complex. Predicted to be active in extracellular space. Orthologous to human CGA (glycoprotein Hormones, alpha polypeptide). [provided by Alliance of Genome Resources, Apr 2022]

Cga 基因产物(1)

mRNA Protein Name
NM_053918.3 NP_446370.3 glycoprotein hormones alpha chain precursor
蛋白主名 其他名称

glycoprotein hormones alpha chain

FSH-alpha

LSH-alpha

TSH-alpha

anterior pituitary glycoprotein hormones common subunit alpha

follicle-stimulating hormone alpha chain

follitropin alpha chain

glycoprotein hormone alpha subunit

glycoprotein hormones, alpha subunit

luteinizing hormon

相关产品

Approval
生物活性分子 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-B0621 Triclabendazole Inhibitor 99.36% 是
Clinical Phase
生物活性分子 (4)
目录号 产品名 作用方式
纯度 Phase
HY-148511 Vidutolimod Agonist / Phase 3
HY-150724 ODN 1018 Agonist 99.28% Phase 2
HY-13735H Quinacrine acetate / Phase 2
HY-160406 SNX281 99.08% Phase 1
Pre-clinical Phase
生物活性分子 (88)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-114180 RU.521 Inhibitor 99.95% 否
HY-131454 SR-717 Agonist 99.89% 否
HY-133916 G140 Inhibitor 99.17% 否
HY-128583 G150 Inhibitor 99.12% 否
HY-150751 ODN TTAGGG Antagonist 99.87% 否
HY-114182 PF-06928215 Inhibitor 99.68% 否
HY-150741 ODN 2216 97.92% 否
HY-P1680 Astin C Inhibitor 99.47% 否
HY-150751C ODN TTAGGG sodium Antagonist 93.80% 否
HY-W021040 Fludioxonil 99.94% 否
HY-139056 SU0268 Inhibitor 99.96% 否
HY-150750 ODN M362 / 否
HY-114181 IRAK4-IN-4 Inhibitor 99.55% 否
HY-149526 cGAS-IN-1 Inhibitor 98.29% 否
HY-160546 cGAS-IN-2 Inhibitor 99.67% 否
HY-131454A SR-717 free acid Agonist 98.05% 否
HY-123230 Trifloxystrobin Inhibitor 99.49% 否
HY-B0821 Pymetrozine Inhibitor ≥99.0% 否
HY-116214 Cyprodinil 99.25% 否
HY-158045 PROTAC PARP1 degrader-1 Inhibitor 99.86% 否
HY-164288 TDI-6570 Inhibitor 99.64% 否
HY-150742 ODN 2336 Agonist 90.74% 否
HY-150748 ODN D-SL01 Agonist 99.94% 否
HY-P5997 XQ2B Inhibitor 99.19% 否
HY-B1331 Cyromazine 99.79% 否
HY-170362 cGAS-IN-4 Inhibitor / 否
HY-172208 PROTAC cGAS degrader-1 Degrader / 否
HY-N2616 Vomicine Inhibitor 99.85% 否
HY-150747 ODN 6016 Inducer / 否
HY-170362A (R)-cGAS-IN-4 Control 99.94% 否
HY-RS02576 CGAS Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-132221 CU-32 Inhibitor 98.8% 否
HY-138646 Poly(deoxyadenylic-thymidylic) acid sodium Activator / 否
HY-116214R Cyprodinil (Standard) / 否
HY-162133 MSA-2-Pt Agonist / 否
HY-W411604 tert-Butyl hex-5-ynoate / 否
HY-115763 3-Aminopropylphosphinic acid Agonist / 否
HY-116214S Cyprodinil-d5 / 否
HY-116214S1 Cyprodinil-13C6 / 否
HY-123230R Trifloxystrobin (Standard) Inhibitor / 否
HY-123230S Trifloxystrobin-d6 Inhibitor / 否
HY-123230S1 Trifloxystrobin-d3 / 否
HY-141831 STF-1084 Inhibitor / 否
HY-144328 STING agonist-10 Activator / 否
HY-144329 STING agonist-11 Activator / 否
HY-148412 Monarsen Inhibitor / 否
HY-150213 ODN BW001 Inhibitor / 否
HY-150751A Biotin-labeled ODN TTAGGG sodium / 否
HY-150751B FITC-labeled ODN TTAGGG sodium Antagonist / 否
HY-158126 G-quadruplex ligand 2 Inhibitor / 否
HY-159925 QKY-613 Activator / 否
HY-162459 cGAS-IN-3 Inhibitor / 否
HY-162944 NA-Ir / 否
HY-162966 MS7829 Degrader / 否
HY-162967 MS8588 / 否
HY-163461 4F-DDC Inhibitor / 否
HY-169225 PDIC-NN Inducer / 否
HY-172218 Lenalidomide-hex-5-ynoic acid / 否
HY-174801 XL-3156 Inhibitor / 否
HY-174802 XL-3158 Inhibitor / 否
HY-176256 endo-S-cGAFMP Agonist / 否
HY-176541 diABZI-Mal Agonist / 否
HY-B0621S Triclabendazole-d3 / 否
HY-B0621S1 Triclabendazole-13C,d3 Inhibitor / 否
HY-B1331S1 Cyromazine-13C3 / 否
HY-N12507 Eupenicisirenin C Inhibitor / 否
HY-P3041 Chromostatin (bovine) Inhibitor / 否
HY-P3864 Pancreastatin (37-52), human Inhibitor / 否
HY-RS02575 CGA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS02577 Cgas Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS02578 Cgas Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS02624 CHGA Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-114730 CGA-JK3 Inhibitor / 否
HY-118578 Furalaxyl Inhibitor 99.3% 否
HY-121165 Cymiazole / 否
HY-12464 Butafenacil / 否
HY-N15159 Cladophorol A Inhibitor / 否
HY-RS17789 Cga Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS18918 Chga Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS24257 Cga Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W010319S 2-Amino-4-methoxy-6-methyl-1,3,5-triazine-d3 / 否
HY-W020788 Benoxacor Agonist 99.39% 否
HY-W021040S Fludioxonil-13C3 / 否
HY-W289054S (S)-Metolachlor metabolite CGA 50720-d3 / 否
HY-W707416S N-(2,6-Dimethylphenyl)-N-(2-(methoxy-d3)acetyl)alanine / 否
HY-W714168S (rac)-Metolachlor metabolite CGA 351916-d3 / 否
HY-W714705S (S)-Metolachlor metabolite CGA 368208-d3 sodium salt / 否
HY-W722289S (rac)-Metolachlor metabolite CGA 50267-d3 / 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P990181 Anti-Mouse myeloperoxidase/MPO Antibody (6G4) Inhibitor 95.00% 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Cga NCBI NCBI:1081
Mus musculus Cga NCBI NCBI:12640
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z